Dermavant Sci Company Profile
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
What is the competitive landscape for DERMAVANT SCI, and when can generic versions of DERMAVANT SCI drugs launch?
DERMAVANT SCI has one approved drug.
There are four US patents protecting DERMAVANT SCI drugs.
There are fifty-eight patent family members on DERMAVANT SCI drugs in thirty-six countries.
Summary for Dermavant Sci
| International Patents: | 58 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Dermavant Sci
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dermavant Sci | VTAMA | tapinarof | CREAM;TOPICAL | 215272-001 | May 23, 2022 | RX | Yes | Yes | 10,426,743 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dermavant Sci | VTAMA | tapinarof | CREAM;TOPICAL | 215272-001 | May 23, 2022 | RX | Yes | Yes | 10,647,649 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Dermavant Sci | VTAMA | tapinarof | CREAM;TOPICAL | 215272-001 | May 23, 2022 | RX | Yes | Yes | 11,458,108 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Dermavant Sci | VTAMA | tapinarof | CREAM;TOPICAL | 215272-001 | May 23, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Dermavant Sci | VTAMA | tapinarof | CREAM;TOPICAL | 215272-001 | May 23, 2022 | RX | Yes | Yes | 10,195,160 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Dermavant Sci Drugs
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
